Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

CRISTINA LAGATOLLA

University of Trieste

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Microbiology

10%

Pharmacology

10%

Antimicrobial Research

30%

Antibiotic Resistance

20%

Antimicrobial Stewardship

20%

Antibiotic Therapy

20%

Membrane Protein

10%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles7

Electrospun Collagen-Coated Nanofiber Membranes Functionalized with Silver Nanoparticles for Advanced Wound Healing Applications

Article Link

Year:

2025

Vascular Graft Impregnation with a Fosfomycin/Oritavancin Combination to Prevent Early Infection

Article Link

Year:

2024

Aspirin and Infection: A Narrative Review

Article Link

Year:

2022

Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. <i>Antibiotics</i> 2021, <i>10</i>, 1341

Article Link

Year:

2022

Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections

Article Link

Year:

2021

Determination of the capsular polysaccharide structure of the Klebsiella pneumoniae ST512 representative strain KPB-1 and assignments of the glycosyltransferases functions

Article Link

Year:

2020

Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients

Article Link

Year:

2020

Collaborators8

Claudia Mauri

University College London

UNITED KINGDOM

M. Cristina Martins

Invited Assistant Professor

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar

PORTUGAL

Gianluca Morroni

RTD-A (assistant professor)

ITALY

Gianluca Turco

Associate Professor

University of Trieste

ITALY

Gianfranco Sanson

University of Trieste

ITALY

lory saveria croce'

Associate Professor

Università degli Studi di Torino

ITALY

Mauro Giuffrè

University of Trieste

ITALY

Roberto Luzzati

Associate Professor

University of Trieste

ITALY

How do I reach out?

Meet Kite AI

CRISTINA LAGATOLLA

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles7

Electrospun Collagen-Coated Nanofiber Membranes Functionalized with Silver Nanoparticles for Advanced Wound Healing Applications

Vascular Graft Impregnation with a Fosfomycin/Oritavancin Combination to Prevent Early Infection

Aspirin and Infection: A Narrative Review

Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New &beta;-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. <i>Antibiotics</i> 2021, <i>10</i>, 1341

Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections

Determination of the capsular polysaccharide structure of the Klebsiella pneumoniae ST512 representative strain KPB-1 and assignments of the glycosyltransferases functions

Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients

Collaborators8

Claudia Mauri

M. Cristina Martins

Gianluca Morroni

Gianluca Turco

Gianfranco Sanson

lory saveria croce'

Mauro Giuffrè

Roberto Luzzati

How do I reach out?

Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. <i>Antibiotics</i> 2021, <i>10</i>, 1341